Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001140361-26-023355
Filing Date
2026-05-29
Accepted
2026-05-29 17:28:48
Documents
2
Group Members
KUVA ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-C ny20068687x3_sctoc.htm SC TO-C 37935
2 EXHIBIT 99.1 ny20068687x3_ex99-1.htm EX-99.1 14149
  Complete submission text file 0001140361-26-023355.txt   53977
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Subject) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-34343 | Film No.: 261046316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1980 POST OAK BLVD, SUITE 100 HOUSTON TX 77056
Business Address 1980 POST OAK BLVD, SUITE 100 HOUSTON TX 77056 917-202-1954
Kuva Labs, Inc. (Filed by) CIK: 0002117902 (see all company filings)

EIN.: 992011547 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C